采用随机开放试验,区纽随机分组,应用环丙沙星对10对呼吸道感染、4对急性软组织化脓性感染及11对肾盂肾炎试验组病人进行前瞻性对照研制。前二组对照药用头孢氨苄、第三组用诺氟沙星。研究结果证实,口服环丙沙星具有抗菌谱广、抗菌作用强特点,优于诺氟沙星及常用的头孢菌素。体外 A randomized open trial was conducted. The patients were randomized into groups. Ciprofloxacin was used to prospectively control 10 pairs of respiratory infections, 4 pairs of acute suppurative soft tissue infections and 11 pairs of pyelonephritis patients. The first two groups of medicinal cephalexin, the third group with norfloxacin. The results confirmed that oral ciprofloxacin has broad antibacterial spectrum, strong antibacterial properties, superior to norfloxacin and commonly used cephalosporins. in vitro